Alpha2-adrenergic agonists for the management of opioid withdrawal
about
Detoxification treatments for opiate dependent adolescentsDihydrocodeine for detoxification and maintenance treatment in illicit opiate-dependent individualsProfile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorderPregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewIs it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Moxonidine for tramadol withdrawal symptoms during detoxification.A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys.Exploring Opioid-Sparing Multimodal Analgesia Options in Trauma: A Nursing Perspective.Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid AddictionOpioid Use in the Twenty First Century: Similarities and Differences Across National Borders.Prolonged Dexmedetomidine Infusion and Drug Withdrawal In Critically Ill Children.Treat the Whole Patient and Be Aware of Drug InteractionsSinomenine Protects Against Morphine Dependence through the NMDAR1/CAMKII/CREB Pathway: A Possible Role of Astrocyte-Derived ExosomesAnti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q24194976-43B06E1B-59AA-4F37-8665-15D8015D0478Q26471618-E0A9DDFD-D864-4DDE-9756-6F1DF96E77C3Q27692647-5C9A4595-ED2A-470E-85F4-6CAA8B47FCB0Q28074617-4209F51D-5FC6-47AB-BCD2-D8A2EEDC1C7EQ34613312-26E7C110-33BC-44AA-9051-8A3BE93857E0Q35844304-777280EF-BF26-4A82-9C7B-BC385F5D84B2Q36603506-01F260D1-065F-4CC8-AA26-DB5F7C205129Q36730570-168C3675-7B34-4449-AB34-67EC0A32E9E4Q37281980-EFA04E28-AD76-4DAF-BA4E-52CBB8B26C26Q37441317-E6DDCBAA-A307-48D1-9B11-6AF0FEC35A76Q42382680-490D1204-A3A3-439A-9105-8BBE12C27EB7Q42389337-221C14E6-D4DF-4508-B976-443621A1E0B2Q54950709-97F75110-2EE8-4D93-BE29-4563092C9E56Q57877670-F1CF3C2A-358B-4165-9D52-0B05B2AB4752Q58691395-FC54841E-4881-4D0E-A75C-97B359C3D6E8Q58788199-EB8AF8C2-A310-40BF-B4FF-49C00AF4B5F1
P2860
Alpha2-adrenergic agonists for the management of opioid withdrawal
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Alpha2-adrenergic agonists for the management of opioid withdrawal
@ast
Alpha2-adrenergic agonists for the management of opioid withdrawal
@en
Alpha2-adrenergic agonists for the management of opioid withdrawal
@nl
type
label
Alpha2-adrenergic agonists for the management of opioid withdrawal
@ast
Alpha2-adrenergic agonists for the management of opioid withdrawal
@en
Alpha2-adrenergic agonists for the management of opioid withdrawal
@nl
prefLabel
Alpha2-adrenergic agonists for the management of opioid withdrawal
@ast
Alpha2-adrenergic agonists for the management of opioid withdrawal
@en
Alpha2-adrenergic agonists for the management of opioid withdrawal
@nl
P2860
P50
P1476
Alpha2-adrenergic agonists for the management of opioid withdrawal
@en
P2093
Jason M White
P2860
P356
10.1002/14651858.CD002024.PUB4
P577
2014-03-31T00:00:00Z